More than 40 years after establishing the first U.S. pharmaceutical joint venture in China, Bristol Myers Squibb is handing ...
U.S. drugmaker Bristol Myers Squibb said on Tuesday it has signed an agreement to sell its 60% ownership stake in a ...
The Bristol-Myers Squibb research complex in Wallingford, which the company plans to vacate at the end of this year. PHOTO CONTRIBUTED Drugmaker Bristol-Myers Squibb said Monday it has added Yale ...
A rendering of BMS at Yard 56, to be located within a new medical building adjacent to Johns Hopkins Bayview Medical Center. It is expected to open in early 2023. (Submitted photo) Baltimore Medical ...
In 2019, Mianna Burnett, manager, Business Operations, Bristol Myers Squibb, and her husband were rocketed into the most trying time in their lives — her husband was diagnosed with cancer. Then, in ...
A Bristol Myers Squibb drug that the pharmaceutical giant added to its pipeline via a multi-billion dollar acquisition now has FDA approval, a decision that makes it the first authorized treatment for ...
As a top cancer executive at Bristol Myers Squibb, Kristen Hege oversaw development of the cell therapy that would become Abecma, the first FDA- approved treatment for multiple myeloma that’s made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback